Calithera Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$3.03 | -$3.03 | -$3.03 |
| Q2 2024 | 0 | -$3.03 | -$3.03 | -$3.03 |
| Q3 2024 | 0 | -$3.03 | -$3.03 | -$3.03 |
| Q4 2024 | 0 | -$3.03 | -$3.03 | -$3.03 |
Calithera Biosciences, Inc. Earnings Date And Information
Calithera Biosciences, Inc. last posted its earnings results on Thursday, March 30th, 2023. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $-1.49 by $2.91. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Calithera Biosciences, Inc. has generated $-4 earnings per share over the last year ($-3.78 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Calithera Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Calithera Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2023 | Q4 2022 | $2.90 | $0 | $0 | ||
| 11/14/2022 | Q3 2022 | -$1.99 | -$2.07 | -0.08 | $8.51 M | $0 |
| 08/16/2022 | Q2 2022 | $1.79 | $3.29 M | $0 | ||
| 05/10/2022 | Q1 2022 | -$3.40 | -$3.53 | -0.13 | $0 | |
| 03/31/2022 | Q4 2021 | -$5.60 | -$31.99 | -26.39 | $0 | |
| 11/09/2021 | Q3 2021 | -$4.60 | -$3.01 | 1.59 | $9.10 M | $6.75 M |
| 08/05/2021 | Q2 2021 | -$4.60 | -$3.86 | 0.74 | $3.52 M | $3.00 M |
| 05/06/2021 | Q1 2021 | -$5.40 | -$5.65 | -0.25 | $0 | |
| 03/16/2021 | Q4 2020 | -$6.40 | -$6.39 | 0.01 | $0 | |
| 11/05/2020 | Q3 2020 | -$6.20 | -$6.44 | -0.24 | $0 | |
| 08/10/2020 | Q2 2020 | -$6.60 | -$5.87 | 0.73 | $0 | |
| 05/07/2020 | Q1 2020 | -$7.40 | -$7.57 | -0.17 | $0 | |
| 03/11/2020 | Q4 2019 | -$7.80 | -$7.89 | -0.09 | $0 | |
| 11/12/2019 | Q3 2019 | -$9.80 | -$7.55 | 2.25 | $0 | |
| 08/08/2019 | Q2 2019 | -$11.00 | -$11.70 | -0.7 | $0 | |
| 05/09/2019 | Q1 2019 | -$8.60 | -$12.19 | -3.59 | $0 | |
| 03/07/2019 | Q4 2018 | -$9.60 | -$10.17 | -0.57 | $0 | |
| 11/07/2018 | Q3 2018 | -$8.20 | -$10.36 | -2.16 | $17.12 M | $0 |
| 08/07/2018 | Q2 2018 | -$6.60 | -$1.71 | 4.89 | $60.68 M | $17.07 M |
| 05/10/2018 | Q1 2018 | -$5.80 | -$7.38 | -1.58 | $5.19 M |
Calithera Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Calithera Biosciences, Inc.'s earnings date?
Calithera Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Calithera Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Calithera Biosciences, Inc. (:CALA) reported $1.42 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.49 by $2.91.
-
How can I listen to Calithera Biosciences, Inc.'s earnings conference call?
The conference call for Calithera Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Calithera Biosciences, Inc.'s conference call transcript?
The conference call transcript for Calithera Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Calithera Biosciences, Inc. generate each year?
Calithera Biosciences, Inc. (:CALA) has a recorded net income of $0. Calithera Biosciences, Inc. has generated $-3.78 earnings per share over the last four quarters.
-
What is Calithera Biosciences, Inc.'s price-to-earnings ratio?
Calithera Biosciences, Inc. (:CALA) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.
